Template:Dgfn2015 Mo 7:00 PCSK9
(Difference between revisions)
Ossip Groth (Talk | contribs) m |
Ossip Groth (Talk | contribs) m |
||
| Line 1: | Line 1: | ||
''dataset not ready 30 citations remianig''' | ''dataset not ready 30 citations remianig''' | ||
| − | {{ | + | {{utp|p=12612979|t=A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease |pdf=http://linkinghub.elsevier.com/retrieve/pii/S0272-6386%2802%2969247-9?showall=true|usr=|}} |
| − | {{ | + | {{utp|p=26331409|t=Implementation of the KDIGO guideline on lipid management requires a substantial increase in statin prescription rates |pdf=http://www.nature.com/ki/journal/vaop/ncurrent/full/ki2015246a.html|usr=|}} |
| − | {{ | + | {{utp|p=19068318|t=The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia |pdf=http://linkinghub.elsevier.com/retrieve/pii/S0002-9149%2808%2901833-X?showall=true|usr=|}} |
| − | {{ | + | {{utp|p=16214597|t=Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins |pdf=http://linkinghub.elsevier.com/retrieve/pii/S0140-6736%2805%2967394-1?showall=true|usr=|}} |
| − | {{ | + | {{utp|p=25815993|t=A century of cholesterol and coronaries: from plaques to genes to statins |pdf=http://www.cell.com/cell/abstract/S0092-8674%2815%2900079-3?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867415000793%3Fshowall%3Dtrue|usr=|}} |
| − | {{ | + | {{utp|p=24160703|t=Targeting PCSK9 for hypercholesterolemia |pdf=http://www.annualreviews.org/doi/abs/10.1146/annurev-pharmtox-011613-140025?url_ver=Z39.88-2003&rfr_dat=cr_pub%3Dpubmed&rfr_id=ori%3Arid%3Acrossref.org&journalCode=pharmtox|usr=|}} |
| − | {{ | + | {{utp|p=22679642|t=The biology and therapeutic targeting of the proprotein convertases |pdf=http://www.nature.com/nrd/journal/v11/n5/full/nrd3699.html|usr=|}} |
{{tp|p=26195630|t=Plasma membrane CD81 complexes with PCSK9 and LDLR and its levels are reduced by PCSK9 |pdf=http://www.jbc.org/content/early/2015/07/20/jbc.M115.642991.full.pdf|usr=|}} | {{tp|p=26195630|t=Plasma membrane CD81 complexes with PCSK9 and LDLR and its levels are reduced by PCSK9 |pdf=http://www.jbc.org/content/early/2015/07/20/jbc.M115.642991.full.pdf|usr=|}} | ||
| − | {{ | + | {{utp|p=16554535|t=Protease variants, LDL, and coronary heart disease |pdf=http://www.nejm.org/doi/full/10.1056/NEJMe068026|usr=|}} |
{{tp|p=17200716|t=Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia |pdf=http://www.jci.org/articles/view/29415/pdf|usr=|}} | {{tp|p=17200716|t=Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia |pdf=http://www.jci.org/articles/view/29415/pdf|usr=|}} | ||
| − | {{ | + | {{utp|p=12730697|t=Mutations in PCSK9 cause autosomal dominant hypercholesterolemia |pdf=http://www.nature.com/ng/journal/v34/n2/full/ng1161.html|usr=|}} |
| − | {{ | + | {{utp|p=23973703|t=Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis |pdf=http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(13)03099-4|usr=|}} |
{{tp|p=19191301|t=Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease |pdf=http://onlinelibrary.wiley.com/doi/10.1002/humu.20882/pdf|usr=|}} | {{tp|p=19191301|t=Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease |pdf=http://onlinelibrary.wiley.com/doi/10.1002/humu.20882/pdf|usr=|}} | ||
Revision as of 18:04, 14 September 2015
dataset not ready 30 citations remianig'
| Journal Paper, restricted access |
| GET A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease Extract PDF direct |
| Journal Paper, restricted access |
| GET Implementation of the KDIGO guideline on lipid management requires a substantial increase in statin prescription rates Extract PDF direct |
| Journal Paper, restricted access |
| GET The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia Extract PDF direct |
| Journal Paper, restricted access |
| GET Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Extract PDF direct |
| Journal Paper, restricted access |
| GET A century of cholesterol and coronaries: from plaques to genes to statins Extract PDF direct |
| Journal Paper, restricted access |
| GET Targeting PCSK9 for hypercholesterolemia Extract PDF direct |
| Journal Paper, restricted access |
| GET The biology and therapeutic targeting of the proprotein convertases Extract PDF direct |
| Journal article, free access |
| GET Plasma membrane CD81 complexes with PCSK9 and LDLR and its levels are reduced by PCSK9 Extract PDF direct |
| Journal Paper, restricted access |
| GET Protease variants, LDL, and coronary heart disease Extract PDF direct |
| Journal article, free access |
| GET Disruption of LDL but not VLDL clearance in autosomal recessive hypercholesterolemia Extract PDF direct |
| Journal Paper, restricted access |
| GET Mutations in PCSK9 cause autosomal dominant hypercholesterolemia Extract PDF direct |
| Journal Paper, restricted access |
| GET Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis Extract PDF direct |
| Journal article, free access |
| GET Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease Extract PDF direct |
| Journal article, free access |
| GET Sequence variations in PCSK9, low LDL, and protection against coronary heart disease Extract PDF direct |
| Journal article, free access |
| GET Longitudinal association of PCSK9 sequence variations with low-density lipoprotein cholesterol levels: the Coronary Artery Risk Development in Young Adults Study Extract PDF direct |
